0001841262-21-000001.txt : 20210120 0001841262-21-000001.hdr.sgml : 20210120 20210120130812 ACCESSION NUMBER: 0001841262-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210120 DATE AS OF CHANGE: 20210120 EFFECTIVENESS DATE: 20210120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RITROVA THERAPEUTICS INC. CENTRAL INDEX KEY: 0001841262 IRS NUMBER: 850990409 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-386817 FILM NUMBER: 21538065 BUSINESS ADDRESS: STREET 1: 37 WASHINGTON SQUARE WEST STREET 2: APT 16D CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: 929-284-5678 MAIL ADDRESS: STREET 1: 37 WASHINGTON SQUARE WEST STREET 2: APT 16D CITY: NEW YORK STATE: NY ZIP: 10011 D 1 primary_doc.xml X0708 D LIVE 0001841262 RITROVA THERAPEUTICS INC. 37 WASHINGTON SQUARE WEST APT 16D NEW YORK NY NEW YORK 10011 929-284-5678 DELAWARE Ritrova Therapeutics LLC None Corporation true 2021 Cristina Maria Alberini 37 Washington Square West Apt 16D New York NY NEW YORK 10011 Executive Officer Director Other Decline to Disclose 06b false 2021-01-11 false true false 0 3000000 150000 2850000 false 2 0 0 0 false RITROVA THERAPEUTICS INC. /s/ Cristina Maria Alberini Cristina Maria Alberini Chief Executive Officer 2021-01-20